Skip to content

Clinical Study of a AVI- TR 01 ointment in Patients with arthritis of knee and low back ache.

A parallel arm interventional Clinical Study to Assess the Efficacy and Tolerability of a AVI- TR 01 ointment in Patients with chronic osteoarthritis of knee and low back ache. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037470
Enrollment
60
Registered
2021-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M190- Primary osteoarthritis of other joints

Interventions

Intervention1: AVI- TR 01 ointment: Apply sufficient amount to the affected area and massage gently. Do not rub. For topical use only. Control Intervention1: Nil: Nil

Sponsors

MN Pharmaceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female subjects aged 30 to 65 years Patients with back pain for at least 3-6 months with score on VAS more than or equal to 4 Patients with Knee pain for at least 3-6 months with score on VAS more than or equal to 4 Suffering from joint discomfort for at least 3 months duration Subjects agreeing to discontinue any use of analgesics during the study. Ready to provide written informed consent Willing to come for the follow-up visits for evaluation

Exclusion criteria

Exclusion criteria: Surgery for low back pain/ knee joint pain in the last 6 months or planning for surgical intervention during the course of the study. Sensitive skin and damaged/ broken skin at the application site. Secondary OA, such as due to injury, inflammatory condition, metabolic or rheumatic disease, osteonecrosis, Pagetâ??s disease, hemophilia etc. Presence of any severe medical or psychological condition Patients participated in another clinical drug trial within 3 months before recruitment in this trial Any other medical condition that in the Investigators opinion would preclude patient participation Subjects with past history of addiction abuse and rehabilitation

Design outcomes

Primary

MeasureTime frame
Changes in pain score with VAS Changes in WOMAC score Changes in severity of other symptoms like swelling, tenderness Timepoint: Baseline, Day 7 and Day 14

Secondary

MeasureTime frame
Assessment of quality of life (QoL) Changes in in requirement of analgesics as a rescue medication Assessment of patient compliance Assessment of study product tolerability Adverse events/ Adverse drug reactions Timepoint: Baseline, Day 7 and Day 14

Countries

India

Contacts

Public ContactMr Ashish Nagaonkar

Mprex Healthcare Pvt. Ltd.

gayatri.mbgindia@gmail.com8554912644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026